Dr. Joseph M. Chalil brings over two decades of experience in healthcare strategy, life sciences, and biotechnology investments. He has held senior leadership positions at global companies including Abbott, Hoffmann-La Roche, Boehringer Ingelheim, and DBV Technologies, contributing to international business development and strategic growth initiatives across the biopharmaceutical and medical sectors. Joseph combines deep clinical and strategic expertise with a strong focus on innovation and sustainable value creation in global healthcare markets.

